473 related articles for article (PubMed ID: 17572079)
41. Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene.
Hwang SM; Lee ES; Shin SH; Kong SY
Korean J Lab Med; 2008 Dec; 28(6):493-7. PubMed ID: 19127115
[TBL] [Abstract][Full Text] [Related]
42. Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations.
Manoukian S; Peissel B; Frigerio S; Lecis D; Bartkova J; Roversi G; Radice P; Bartek J; Delia D
Breast Cancer Res Treat; 2011 Nov; 130(1):207-15. PubMed ID: 21562711
[TBL] [Abstract][Full Text] [Related]
43. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS
N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143
[TBL] [Abstract][Full Text] [Related]
45. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
46. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age.
Trkova M; Prochazkova K; Krutilkova V; Sumerauer D; Sedlacek Z
Cancer; 2007 Aug; 110(3):694-702. PubMed ID: 17567834
[TBL] [Abstract][Full Text] [Related]
47. The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: case report.
Vranic S; Kapur L; Foco F; Bilalovic N; Hainaut P
Pathologica; 2006 Apr; 98(2):156-9. PubMed ID: 16929790
[TBL] [Abstract][Full Text] [Related]
48. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
Ognjanovic S; Olivier M; Bergemann TL; Hainaut P
Cancer; 2012 Mar; 118(5):1387-96. PubMed ID: 21837677
[TBL] [Abstract][Full Text] [Related]
49. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
50. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
[TBL] [Abstract][Full Text] [Related]
51. Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family.
Varley JM; Chapman P; McGown G; Thorncroft M; White GR; Greaves MJ; Scott D; Spreadborough A; Tricker KJ; Birch JM; Evans DG; Reddel R; Camplejohn RS; Burn J; Boyle JM
Oncogene; 1998 Jun; 16(25):3291-8. PubMed ID: 9681828
[TBL] [Abstract][Full Text] [Related]
52. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
[TBL] [Abstract][Full Text] [Related]
53. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
[TBL] [Abstract][Full Text] [Related]
54. [Sequence analysis of BRCA1 gene in young breast cancer patients and/or positive family history].
Hampl M; Plaschke J; Burgemeister R; Schwarz P; Saeger HD; Schackert HK
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):267-72. PubMed ID: 14518257
[TBL] [Abstract][Full Text] [Related]
55. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.
Krutilkova V; Trkova M; Fleitz J; Gregor V; Novotna K; Krepelova A; Sumerauer D; Kodet R; Siruckova S; Plevova P; Bendova S; Hedvicakova P; Foreman NK; Sedlacek Z
Eur J Cancer; 2005 Jul; 41(11):1597-603. PubMed ID: 15925506
[TBL] [Abstract][Full Text] [Related]
56. Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India.
Vinodkumar B; Syamala V; Abraham EK; Balakrishnan R; Ankathil R
J Exp Clin Cancer Res; 2007 Sep; 26(3):329-36. PubMed ID: 17987791
[TBL] [Abstract][Full Text] [Related]
57. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi OP; Nevanlinna H; Winqvist R
Br J Cancer; 2001 Jan; 84(1):116-9. PubMed ID: 11139324
[TBL] [Abstract][Full Text] [Related]
58. Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
Birch JM; Alston RD; McNally RJ; Evans DG; Kelsey AM; Harris M; Eden OB; Varley JM
Oncogene; 2001 Aug; 20(34):4621-8. PubMed ID: 11498785
[TBL] [Abstract][Full Text] [Related]
59. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.
Mazoyer S; Lalle P; Moyret-Lalle C; Marçais C; Schraub S; Frappaz D; Sobol H; Ozturk M
Oncogene; 1994 Apr; 9(4):1237-9. PubMed ID: 8134127
[TBL] [Abstract][Full Text] [Related]
60. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
